Skip To Content

News & Events

Given the activity level of our attorneys, we are confident in showcasing the various matters that our clients have given us the privilege to work on and approved to post here.

Posts

  • February 15 2012

    Cardium Therapeutics, Inc. announced the closing of their Registered Direct in the amount of $5,000,000. EG&S acted as counsel to the placement agent.
     

  • February 14 2012

    Apps Genius Corp announced the closing of their Registered Direct offering in the amount of $1,000,000.  EG&S acted as counsel to the placement agent.

  • February 10 2012

    EpiCept Corporation announced the closing of their Registered Direct offering in the amount of $2,000,000. EG&S acted as counsel to the placement agent.
     

  • February 10 2012

    Neuralstem, Inc. announced the closing of their Registered Direct offering in the amount of $5,050,000.  EG&S acted as counsel to the placement agent.
     

  • February 09 2012

    Advaxis, Inc. announced the closing of their PIPE offering in the amount of $1,047,500. EG&S acted as counsel to the placement agent.
     

  • February 07 2012

    Spherix Incorporated announced the closing of their Registered Direct offering in the amount of $1,150,001. EG&S acted as counsel to the placement agent.
     

  • February 06 2012

    Jones Soda Co. announced the closing of their Registered Direct offering in the amount of $3,207,500. EG&S acted as counsel to the placement agent.
     

  • February 03 2012

    Generex Biotechnology Corporation announced the closing of their PIPE offering in the amount of $2,000,000. EG&S acted as counsel to Generex.
     

“It’s with genuine appreciation to all of our clients that we are in a position to achieve and maintain our leadership position in so many areas.”